The latest ‘Guidelines for Good Distribution Practice of Medical Products for Human Use (GDP)’ came into force in March 2013 to ensure control of the supply chain and, consequently, maintain the quality and integrity of medicinal products.
Wallenborn was one of the first transport companies to achieve GDP certification and has used this prestigious and rare accreditation as a platform to develop specialised services for the life sciences sector. Its procedures and practices have fully embraced GDP, notably the integration of quality management, operations, personnel training and control, documentation and continuous improvement.